Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wockhardt Ltd.

www.wockhardtin.com

Latest From Wockhardt Ltd.

Torrent Makes A ‘Cautious’ Comeback With Losartan In US

Torrent restarts sale of losartan in the US, exercising caution to ensure the API sourced is “impurity free.” Timely resolution of compliance deviations at the firm’s Indian sites is also critical for growth momentum in the US.

Compliance Sales & Earnings

Torrent Makes ‘Cautious’ Comeback With Losartan In US

Torrent restarts sale of losartan in the US, exercising caution to ensure the API sourced is “impurity free.” Timely resolution of compliance deviations at the firm’s Indian sites is also critical for growth momentum in the US.

Compliance Sales & Earnings

Buyout Firms Eye Wockhardt’s Domestic Formulations Unit

Private-equity firms are reportedly in talks to acquire a controlling stake in the domestic formulations business of India’s Wockhardt, which is seeking funds to pay down significant debts.

Deals Strategy

People Round-Up: Bhadauria Named As Amneal CSO

Amneal gets a new CSO, Acino restructures its board under a new chair, the AAM adds an assistant general counsel and the British Biosimilars Association names a vice-chair, as well as other people movements from around the generics, biosimilars and value-added medicines industries.

Appointments Strategy
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register